Who founded Geneticure?

Geneticure was founded by Scott Snyder in 2013.

Who are Geneticure's investors?

Geneticure's investors include Wireframe Ventures.

How much funding has Geneticure raised?

Geneticure has disclosed $1.1M raised across 3 rounds.

Where is Geneticure headquartered?

Geneticure is headquartered in Eden Prairie, US.

Geneticure

Eden Prairie, US · Founded 2013 · Delaware corporation · 9 employees on LinkedIn · 1 known investors

Find your way into Geneticure

850 people in our graph share verified history with the Geneticure team — schools, employers, funds. One of them is your warm intro.

Greg Rudinunlockedknows Scott Snyder · together at Creative Destruction Lab

×11knows the team · via Creative Destruction Lab

Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.

Biotech Digital Health Healthtech Medical Devices

Founders & leadership

Geneticure was founded in 2013 by Scott Snyder.

Scott Snyder Founder · CEOScott Snyder is CEO of Geneticure, a precision medicine company backed by Mayo Clinic that develops genetic testing to guide treatment selection for hypertension.

Eric SnyderChief Operating Officer

Ryan SprisslerChief Scientific Officer

Tom OlsonChief Clinical Officer

Investors · 1

Wireframe Ventureslisted by Wireframe VenturesSan Francisco · $500K – $2M

How we know: Wireframe Ventures's portfolio page · the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$1.1M disclosed across 3 rounds · 2016–2017

▶$200KraisedApr 2017 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Scott SnyderExecutive Officer, Director

Offering amount: $750K
Amount sold: $200K
First sale: Mar 2017
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$250KraisedOct 2016 · 1 investors · Biotechnology

Rule 506(b)

Officers, directors & promoters on the filing

Scott SnyderExecutive Officer

Offering amount: $400K
Amount sold: $250K
Minimum investment: $50K
First sale: Oct 2016
Incorporated: Corporation, Delaware, 2013
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

▶$665KraisedMay 2016 · 7 investors · Biotechnology

Officers, directors & promoters on the filing

SCOTT SNYDERExecutive Officer
BEN BOWMANExecutive Officer
ERIC SYNDERExecutive Officer
RYAN SPRISSLERExecutive Officer
THOMAS OLSONExecutive Officer

Offering amount: $890K
Amount sold: $665K
Minimum investment: $25K
First sale: Mar 2016
Incorporated: Limited Liability Company, Minnesota, 2013
Federal exemptions: 04.1

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Competitors · 5

by search overlap

Quest Diagnostics28 shared keywordsQuest Diagnostics is the world's leading provider of diagnostic information services, serving one in three adult Americans and half of US physicians and hospitals. The company offers diagnostic insights and testing services to consumers and healthcare providers to support health decision-making.

Genomind27 shared keywordsGenMedPro is a genetics-based medication management platform that analyzes 26 genes to identify drug-drug and gene-drug interactions across a patient's entire medication regimen. The platform serves healthcare providers and care teams to reduce prescribing errors, prevent adverse events, and optimize medication safety for complex polypharmacy cases.

Labcorp24 shared keywordsLabCorp provides diagnostic testing services and clinical trial recruitment solutions that connect patient insights to drug development for healthcare providers.

Self Decode17 shared keywordsSelfDecode is a consumer genomics platform that analyzes users' DNA, blood test results, and lifestyle data to generate 1,500+ personalized health reports and AI-driven recommendations on diet, supplements, and lifestyle. It sells DNA test kits and subscription access to tools including an AI health assistant (DecodyGPT) and lab analysis, serving consumers, doctors, and businesses.

23andMe16 shared keywords23andMe operates a research platform that collects genetic data from millions of users to advance genomic research and health discovery. The company enables individuals to learn about their genetic traits while contributing to medical research studies that benefit public health.

Companies competing with Geneticure for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Geneticure do?: Geneticure offers a patented genetic test that uses a cheek-swab DNA sample, analyzing 17 genotypes across 11 genes to recommend personalized hypertension (blood pressure) treatment plans. The test helps doctors prescribe effective treatments by assessing the responsiveness of the patient's cardiac, vascular, and renal systems, reducing trial-and-error prescribing.
Who founded Geneticure?: Geneticure was founded by Scott Snyder in 2013.
Who are Geneticure's investors?: Geneticure's investors include Wireframe Ventures.
How much funding has Geneticure raised?: Geneticure has disclosed $1.1M raised across 3 rounds.
Where is Geneticure headquartered?: Geneticure is headquartered in Eden Prairie, US.